GREY:IMVIQ - Post by User
Post by
Breakthorough1on Apr 08, 2020 2:59am
579 Views
Post# 30889270
Age of people for Covid-19 trial
Age of people for Covid-19 trialIMV will vaccinate older people. MODERNA: "This is a phase I, open-label, dose-ranging clinical trial in males and non-pregnant females, 18 to 55 years" INOVIO: "Ages Eligible for Study: 18 Years to 50 Years" IMV: "So, we are. We are planning to do a trial in 18 to 64, which has been different from, I think, what is being done in the US and in some other trials. The 50 to 64 is a population that is considered as some type of surrogate for the elderly population. It's difficult to do your first Phase I study safety, as you can imagine, indirectly into the elderly population and the compromised population. But what has been done in Canada, and the CIRN network has done a lot of studies this way, you can get a sense of what you can expect to see in the elderly population by studying that sub population between 50 to 64"